By targeting and disabling a protein frequently found in melanoma tumors, doctors may be able to make the cancer more vulnerable to chemotherapy, according to a new study.
Although this study was done in laboratory rats, a clinical trial applying the same concept to humans has already begun at four comprehensive cancer centers nationwide.
laboratory ratsTargeted Therapy Plus Chemotherapy May Pack 1-2 Punch Against Me...ScienceDaily Fri, 05/16/2008 - 09:15
|
